Intrigued by these results, we hypothesised that this regulatory activity was conserved across the L1PA2 subfamily, and developed a bioinformatic pipeline for the integrated analysis of transcription factor binding and transcriptomic data to identify L1PA2-derived TF binding and promoter activity in breast cancer cells. Here, TF is linked to breast carcinoma.